Is it time to leave the avoidance of rupture of membranes for women infected with HIV and receiving cART in the past?
BJOG
.
2016 May;123(6):982.
doi: 10.1111/1471-0528.13445.
Epub 2015 May 22.
Author
C Eppes
1
Affiliation
1
Baylor College of Medicine, Houston, TX, USA.
PMID:
25998194
DOI:
10.1111/1471-0528.13445
No abstract available
Publication types
Comment
MeSH terms
Anti-HIV Agents / therapeutic use*
Antiretroviral Therapy, Highly Active*
Female
HIV Infections / drug therapy
HIV-1
Humans
Viral Load
Substances
Anti-HIV Agents